PCAS
1st Half 2020 Earnings Report
Ecully, September 8, 2020
1st HALF 2020 EARNINGS REPORT
PCAS (Euronext Paris: PCA), a specialist in the development and production of complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated earnings for the first half of 2020.
30 June 2019 | 30 June 2020 | |||||||
in millions of euros | ||||||||
Net sales | 102.3 | 105.1 | ||||||
EBITDA (*) | 7.2 | 7.2 | ||||||
EBITDA margin | 7.1% | 6.9% | ||||||
Current operating income (*) | -1.5 | -3.0 | ||||||
Other operating income and expenses | -5.4 | -0.2 | ||||||
Operating income | -6.9 | -3.2 | ||||||
Financial result | -0.7 | -1.5 | ||||||
Taxes | -1.2 | -1.1 | ||||||
Net result | -8.7 | -5.8 | ||||||
(*) of which research tax credit (CIR): 2.2 M€ in 2019 and 2.1 M€ in 2020 |
Lesen Sie auch
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte